{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:17:30Z","timestamp":1792793850146,"version":"4.5.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06062-w","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:06:49Z","timestamp":1784268409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting Sirtuin Signaling in Parkinson\u2019s Disease and Neurodegeneration: Molecular Insights and Translational Potential"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-7872","authenticated-orcid":false,"given":"Shobha","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9708-1642","authenticated-orcid":false,"given":"Hemraj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7975-7991","authenticated-orcid":false,"given":"Shravani","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2147-2990","authenticated-orcid":false,"given":"Rajeev","family":"Taliyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"6062_CR1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148288","author":"CS Colwell","year":"2021","unstructured":"Colwell CS (2021) Defining circadian disruption in neurodegenerative disorders. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI148288","journal-title":"J Clin Invest"},{"key":"6062_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2008.02.010","author":"TF Outeiro","year":"2008","unstructured":"Outeiro TF, Marques O, Kazantsev A (2008) Therapeutic role of sirtuins in neurodegenerative disease. Biochimica et Biophysica Acta (BBA) - Mol Basis of Dise. https:\/\/doi.org\/10.1016\/j.bbadis.2008.02.010","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Basis of Dise"},{"key":"6062_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2013.00053","author":"SW Min","year":"2013","unstructured":"Min SW, Sohn PD, Cho SH, Swanson RA, Gan L (2013) Sirtuins in neurodegenerative diseases: an update on potential mechanisms. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2013.00053","journal-title":"Front Aging Neurosci"},{"key":"6062_CR4","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2009.5.3.120","author":"SH Han","year":"2009","unstructured":"Han SH (2009) Potential role of sirtuin as a therapeutic target for neurodegenerative diseases. J Clin Neurol. https:\/\/doi.org\/10.3988\/jcn.2009.5.3.120","journal-title":"J Clin Neurol"},{"key":"6062_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2016.11.022","author":"M Ajami","year":"2017","unstructured":"Ajami M, Pazoki-Toroudi H, Amani H, Nabavi SF, Braidy N, Vacca RA, Atanasov AG et al (2017) Therapeutic role of sirtuins in neurodegenerative disease and their modulation by polyphenols. Neurosci Biobehav Rev. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.11.022","journal-title":"Neurosci Biobehav Rev"},{"key":"6062_CR6","doi-asserted-by":"publisher","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","DOI":"10.1016\/S0140-6736(14)61393-3"},{"key":"6062_CR7","doi-asserted-by":"publisher","unstructured":"Schapira AHV (2004)\u00a0Disease modification in Parkinson\u2019s disease. Lancet Neurol 3(6):362\u2013368. https:\/\/doi.org\/10.1016\/S1474-4422(04)00768-7","DOI":"10.1016\/S1474-4422(04)00768-7"},{"key":"6062_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(03)00568-3","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron. https:\/\/doi.org\/10.1016\/S0896-6273(03)00568-3","journal-title":"Neuron"},{"key":"6062_CR9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R112.378877","author":"JL Feldman","year":"2012","unstructured":"Feldman JL, Dittenhafer-Reed KE, Denu JM (2012) Sirtuin catalysis and regulation. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.R112.378877","journal-title":"J Biol Chem"},{"key":"6062_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2012.07.004","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Luo P, Guo Q, Li S, Zhang L, Zhao M, Xu H et al (2012) Interactions between SIRT1 and MAPK\/ERK regulate neuronal apoptosis induced by traumatic brain injury in vitro and in vivo. Exp Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2012.07.004","journal-title":"Exp Neurol"},{"key":"6062_CR11","doi-asserted-by":"publisher","DOI":"10.4103\/2394-8108.162532","author":"K Koronowski","year":"2015","unstructured":"Koronowski K, Perez-Pinzon M (2015) Sirt1 in cerebral ischemia. Brain Circ. https:\/\/doi.org\/10.4103\/2394-8108.162532","journal-title":"Brain Circ"},{"key":"6062_CR12","doi-asserted-by":"publisher","unstructured":"Srivastava S, Haigis MC (2011) Role of sirtuins and calorie restriction in neuroprotection: implications in alzheimers and Parkinsons diseases. Curr Pharm Des. https:\/\/doi.org\/10.2174\/138161211798072526","DOI":"10.2174\/138161211798072526"},{"key":"6062_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23806","author":"BL Tang","year":"2017","unstructured":"Tang BL (2017) Sirtuins as modifiers of Parkinson\u2019s disease pathology. J Neurosci Res. https:\/\/doi.org\/10.1002\/jnr.23806","journal-title":"J Neurosci Res"},{"key":"6062_CR14","doi-asserted-by":"publisher","unstructured":"Greco G (2023) Neuromelanin and Parkinson\u2019s disease. In: Handbook of neurotoxicity, 2nd edn. https:\/\/doi.org\/10.1007\/978-3-031-15080-7_12","DOI":"10.1007\/978-3-031-15080-7_12"},{"key":"6062_CR15","doi-asserted-by":"crossref","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303","DOI":"10.1016\/S0140-6736(21)00218-X"},{"key":"6062_CR16","doi-asserted-by":"publisher","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B et al (1997) Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science (80-. ). https:\/\/doi.org\/10.1126\/science.276.5321.2045","DOI":"10.1126\/science.276.5321.2045"},{"key":"6062_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.242","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H (2013) 100 years of Lewy pathology. Nat Rev Neurol. https:\/\/doi.org\/10.1038\/nrneurol.2012.242","journal-title":"Nat Rev Neurol"},{"key":"6062_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.11.004","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2009.11.004","journal-title":"Neurobiol Dis"},{"key":"6062_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01257-8","author":"QJ Wu","year":"2022","unstructured":"Wu QJ, Zhang TN, Chen HH, Yu XF, Lv JL, Liu YY, Liu YS et al (2022) The sirtuin family in health and disease. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-022-01257-8","journal-title":"Signal Transduct Target Ther"},{"key":"6062_CR20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R112.402768","author":"C Sebastia\u0144","year":"2012","unstructured":"Sebastia\u0144 C, Satterstrom FK, Haigis MC, Mostoslavsky R (2012) From sirtuin biology to human diseases: an update. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.R112.402768","journal-title":"J Biol Chem"},{"key":"6062_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2009.09.009","author":"BD Sanders","year":"2010","unstructured":"Sanders BD, Jackson B, Marmorstein R (2010) Structural basis for sirtuin function: what we know and what we don\u2019t. Biochimica et Biophysica Acta (BBA). https:\/\/doi.org\/10.1016\/j.bbapap.2009.09.009","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"6062_CR22","doi-asserted-by":"publisher","DOI":"10.1210\/me.2007-0079","author":"H Yamamoto","year":"2007","unstructured":"Yamamoto H, Schoonjans K, Auwerx J (2007) Sirtuin functions in health and disease. Mol Endocrinol. https:\/\/doi.org\/10.1210\/me.2007-0079","journal-title":"Mol Endocrinol"},{"key":"6062_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2013.12.001","author":"HC Chang","year":"2014","unstructured":"Chang HC, Guarente L (2014) SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab. https:\/\/doi.org\/10.1016\/j.tem.2013.12.001","journal-title":"Trends Endocrinol Metab"},{"key":"6062_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1104969108","author":"B Beirowski","year":"2011","unstructured":"Beirowski B, Gustin J, Armour SM, Yamamoto H, Viader A, North BJ, Mich\u00e1n S et al (2011) Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3\/atypical protein kinase C (aPKC) signaling. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.1104969108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6062_CR25","doi-asserted-by":"publisher","unstructured":"He Y, Wu Z, Xu L, Xu K, Chen Z, Ran J, Wu L (2020) The role of SIRT3-mediated mitochondrial homeostasis in osteoarthritis. Cell Mol Life Sci 77. https:\/\/doi.org\/10.1007\/s00018-020-03497-9","DOI":"10.1007\/s00018-020-03497-9"},{"key":"6062_CR26","doi-asserted-by":"publisher","unstructured":"Nasrin N, Wu X, Fortier E, Feng Y, Bar\u00e9 OC, Chen S, Ren X et al (2010) SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J Biol Chem 285. https:\/\/doi.org\/10.1074\/jbc.M110.124164","DOI":"10.1074\/jbc.M110.124164"},{"key":"6062_CR27","doi-asserted-by":"publisher","first-page":"311 \u2013334","DOI":"10.1080\/10409238.2018.1458071","volume":"53","author":"S Kumar","year":"2018","unstructured":"Kumar S, Lombard DB (2018) Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology. Crit Rev Biochem Mol Biol 53:311\u2013334. https:\/\/doi.org\/10.1080\/10409238.2018.1458071","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"6062_CR28","doi-asserted-by":"publisher","unstructured":"Yang X, Feng J, Liang W, Zhu Z, Chen Z, Hu J, Yang D et al (2022) Roles of SIRT6 in kidney disease: a novel therapeutic target. Cell Mol Life Sci 79. https:\/\/doi.org\/10.1007\/s00018-021-04061-9","DOI":"10.1007\/s00018-021-04061-9"},{"key":"6062_CR29","doi-asserted-by":"publisher","unstructured":"Vazquez BN, Thackray JK, Serrano L (2017) Sirtuins and DNA damage repair: SIRT7 comes to play. Nucleus 8. https:\/\/doi.org\/10.1080\/19491034.2016.1264552","DOI":"10.1080\/19491034.2016.1264552"},{"key":"6062_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddtec.2012.08.003","author":"W Dang","year":"2014","unstructured":"Dang W (2014) The controversial world of sirtuins. Drug Discov Today Technol. https:\/\/doi.org\/10.1016\/j.ddtec.2012.08.003","journal-title":"Drug Discov Today Technol"},{"key":"6062_CR31","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2013.37.5.315","author":"M Kitada","year":"2013","unstructured":"Kitada M, Koya D (2013) SIRT1 in type 2 diabetes: mechanisms and therapeutic potential. Diabetes Metab J. https:\/\/doi.org\/10.4093\/dmj.2013.37.5.315","journal-title":"Diabetes Metab J"},{"key":"6062_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr326","author":"MM Maxwell","year":"2011","unstructured":"Maxwell MM, Tomkinson EM, Nobles J, Wizeman JW, Amore AM, Quinti L, Chopra V et al (2011) The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddr326","journal-title":"Hum Mol Genet"},{"key":"6062_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.09.004","author":"HS Kim","year":"2011","unstructured":"Kim HS, Vassilopoulos A, Wang RH, Lahusen T, Xiao Z, Xu X, Li C et al (2011) SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC\/C activity. Cancer Cell. https:\/\/doi.org\/10.1016\/j.ccr.2011.09.004","journal-title":"Cancer Cell"},{"key":"6062_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2011.05.008","author":"EL Bell","year":"2011","unstructured":"Bell EL, Guarente L (2011) The SirT3 divining rod points to oxidative stress. Mol Cell. https:\/\/doi.org\/10.1016\/j.molcel.2011.05.008","journal-title":"Mol Cell"},{"key":"6062_CR35","doi-asserted-by":"publisher","unstructured":"Kumar S, Lombard DB (2017) For certain, SIRT4 activities! Trends Biochem Sci. https:\/\/doi.org\/10.1016\/j.tibs.2017.05.008","DOI":"10.1016\/j.tibs.2017.05.008"},{"key":"6062_CR36","doi-asserted-by":"publisher","DOI":"10.1096\/fj.13-245241","author":"M Buler","year":"2014","unstructured":"Buler M, Aatsinki SM, Izzi V, Uusimaa J, Hakkola J (2014) SIRT5 is under the control of PGC-1o: And AMPK and is involved in regulation of mitochondrial energy metabolism. FASEB J. https:\/\/doi.org\/10.1096\/fj.13-245241","journal-title":"FASEB J"},{"key":"6062_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2372-4","author":"W Lu","year":"2014","unstructured":"Lu W, Zuo Y, Feng Y, Zhang M (2014) SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer. Tumor Biol. https:\/\/doi.org\/10.1007\/s13277-014-2372-4","journal-title":"Tumor Biol"},{"key":"6062_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.10.033","author":"ZF Lin","year":"2013","unstructured":"Lin ZF, Xu HB, Wang JY, Lin Q, Ruan Z, Liu FB, Jin W et al (2013) SIRT5 desuccinylates and activates SOD1 to eliminate ROS. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2013.10.033","journal-title":"Biochem Biophys Res Commun"},{"key":"6062_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.06.018","author":"D Toiber","year":"2013","unstructured":"Toiber D, Erdel F, Bouazoune K, Silberman DM, Zhong L, Mulligan P, Sebastian C et al (2013) SIRT6 recruits SNF2H to DNA break sites, preventing genomic instability through chromatin remodeling. Mol Cell. https:\/\/doi.org\/10.1016\/j.molcel.2013.06.018","journal-title":"Mol Cell"},{"key":"6062_CR40","doi-asserted-by":"publisher","unstructured":"Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, Seluanov A et al (2011) SIRT6 promotes DNA repair under stress by activating PARP1. Science (80-. ). https:\/\/doi.org\/10.1126\/science.1202723","DOI":"10.1126\/science.1202723"},{"key":"6062_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.10.002","author":"L Tasselli","year":"2017","unstructured":"Tasselli L, Zheng W, Chua KF (2017) SIRT6: novel mechanisms and links to aging and disease. Trends Endocrinol Metab. https:\/\/doi.org\/10.1016\/j.tem.2016.10.002","journal-title":"Trends Endocrinol Metab"},{"key":"6062_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04342-x","author":"FA Lagunas-Rangel","year":"2022","unstructured":"Lagunas-Rangel FA (2022) SIRT7 in the aging process. Cell Mol Life Sci. https:\/\/doi.org\/10.1007\/s00018-022-04342-x","journal-title":"Cell Mol Life Sci"},{"key":"6062_CR43","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201593499","author":"BN Vazquez","year":"2016","unstructured":"Vazquez BN, Thackray JK, Simonet NG, Kane\u2010Goldsmith N, Martinez\u2010Redondo P, Nguyen T, Bunting S et al (2016) SIRT 7 promotes genome integrity and modulates non\u2010homologous end joining DNA repair. EMBO J. https:\/\/doi.org\/10.15252\/embj.201593499","journal-title":"EMBO J"},{"key":"6062_CR44","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M111.015156","author":"YC Tsai","year":"2012","unstructured":"Tsai YC, Greco TM, Boonmee A, Miteva Y, Cristea IM (2012) Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription. Mol Cell Proteomics. https:\/\/doi.org\/10.1074\/mcp.M111.015156","journal-title":"Mol Cell Proteomics"},{"key":"6062_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.02.005","author":"G Srivastava","year":"2012","unstructured":"Srivastava G, Dixit A, Yadav S, Patel DK, Prakash O, Singh MP (2012) Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse. Free Radic Biol Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.02.005","journal-title":"Free Radic Biol Med"},{"key":"6062_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9124-3","author":"MS ur Rasheed","year":"2016","unstructured":"ur Rasheed MS, Tripathi MK, Mishra AK, Shukla S, Singh MP (2016) Resveratrol protects from toxin-induced parkinsonism: plethora of proofs hitherto petty translational value. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-015-9124-3","journal-title":"Mol Neurobiol"},{"key":"6062_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0850-z","author":"G Mud\u00f2","year":"2012","unstructured":"Mud\u00f2 G, M\u00e4kel\u00e4 J, Di Liberto V, Tselykh TV, Olivieri M, Piepponen P, Eriksson O et al (2012) Transgenic expression and activation of PGC-1\u03b1 protect dopaminergic neurons in the MPTP mouse model of Parkinsons disease. Cell Mol Life Sci. https:\/\/doi.org\/10.1007\/s00018-011-0850-z","journal-title":"Cell Mol Life Sci"},{"key":"6062_CR48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501485200","author":"S Nemoto","year":"2005","unstructured":"Nemoto S, Fergusson MM, Finkel T (2005) SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1\u03b1. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M501485200","journal-title":"J Biol Chem"},{"key":"6062_CR49","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.6386.1","author":"Y Kitao","year":"2015","unstructured":"Kitao Y, Ageta-Ishihara N, Takahashi R, Kinoshita M, Hori O (2015) Transgenic supplementation of SIRT1 fails to alleviate acute loss of nigrostriatal dopamine neurons and gliosis in a mouse model of MPTP-induced parkinsonism. F1000Res. https:\/\/doi.org\/10.12688\/f1000research.6386.1","journal-title":"F1000Res"},{"key":"6062_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116919","author":"X Chen","year":"2015","unstructured":"Chen X, Wales P, Quinti L, Zuo F, Moniot S, Herisson F, Rauf NA et al (2015) The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson\u2019s disease but not amyotrophic lateral sclerosis and cerebral ischemia. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0116919","journal-title":"PLoS ONE"},{"key":"6062_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-016-1892-2","author":"JY Zhang","year":"2016","unstructured":"Zhang JY, Deng YN, Zhang M, Su H, Qu QM (2016) SIRT3 acts as a neuroprotective agent in rotenone-induced Parkinson cell model. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-016-1892-2","journal-title":"Neurochem Res"},{"key":"6062_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00372","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhang Y, Zhu K, Chi S, Wang C, Xie A (2020) Emerging role of sirtuin 2 in Parkinson\u2019s disease. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2019.00372","journal-title":"Front Aging Neurosci"},{"key":"6062_CR53","doi-asserted-by":"publisher","unstructured":"Murato\u01e7lu S (2020)\u00a0Sirtuins: key enzymes in age-related diseases. J Cell Neurosci Oxidative Stress 12(1):739\u2013761. https:\/\/doi.org\/10.17756\/jcnos.2020.12.1.739","DOI":"10.17756\/jcnos.2020.12.1.739"},{"key":"6062_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep12613","author":"T Tomita","year":"2015","unstructured":"Tomita T, Hamazaki J, Hirayama S, McBurney MW, Yashiroda H, Murata S (2015) Sirt1-deficiency causes defective protein quality control. Sci Rep. https:\/\/doi.org\/10.1038\/srep12613","journal-title":"Sci Rep"},{"key":"6062_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2000374","author":"RM de Oliveira","year":"2017","unstructured":"de Oliveira RM, Vicente Miranda H, Francelle L, Pinho R, Szeg\u00f6 \u00c9M, Martinho R, Munari F et al (2017) The mechanism of sirtuin 2\u2013mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol. https:\/\/doi.org\/10.1371\/journal.pbio.2000374","journal-title":"PLoS Biol"},{"key":"6062_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10787-022-01125-5.10.1007\/s10787-022-01125-5","volume":"31","author":"GES Batiha","year":"2023","unstructured":"Batiha GES, Al-kuraishy HM, Al-Gareeb AI, Elekhnawy E (2023) SIRT1 pathway in Parkinson\u2019s disease: a faraway snapshot but so close. Inflammopharmacology 31:37\u201356. https:\/\/doi.org\/10.1007\/s10787-022-01125-5.10.1007\/s10787-022-01125-5","journal-title":"Inflammopharmacology"},{"key":"6062_CR57","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.14336\/AD.2020.0216","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, Feng Y, Wang XX, Truong D, Wu YC (2020) The critical role of SIRT1 in Parkinson\u2019s disease: mechanism and therapeutic considerations. Aging Dis 11:1608\u20131622. https:\/\/doi.org\/10.14336\/AD.2020.0216","journal-title":"Aging Dis"},{"key":"6062_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-022-03560-w","author":"L He","year":"2022","unstructured":"He L, Wang J, Yang Y, Li J, Tu H (2022) Mitochondrial sirtuins in Parkinson\u2019s disease. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-022-03560-w","journal-title":"Neurochem Res"},{"key":"6062_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2018.09.005","author":"JJ Lemasters","year":"2018","unstructured":"Lemasters JJ, Zhong Z (2018) Mitophagy in hepatocytes: types, initiators and role in adaptive ethanol metabolism. Liver Res. https:\/\/doi.org\/10.1016\/j.livres.2018.09.005","journal-title":"Liver Res"},{"key":"6062_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/nature13418","author":"B Bingol","year":"2014","unstructured":"Bingol B, Tea JS, Phu L, Reichelt M, Bakalarski CE, Song Q, Foreman O et al (2014) The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature. https:\/\/doi.org\/10.1038\/nature13418","journal-title":"Nature"},{"key":"6062_CR61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712145105","author":"HL In","year":"2008","unstructured":"In HL, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, Tsokos M et al (2008) A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.0712145105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6062_CR62","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.024406","author":"A Sengupta","year":"2009","unstructured":"Sengupta A, Molkentin JD, Yutzey KE (2009) FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M109.024406","journal-title":"J Biol Chem"},{"key":"6062_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1730","author":"E Tasdemir","year":"2008","unstructured":"Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D\u2019Amelio M, Criollo A et al (2008) Regulation of autophagy by cytoplasmic p53. Nat Cell Biol. https:\/\/doi.org\/10.1038\/ncb1730","journal-title":"Nat Cell Biol"},{"key":"6062_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00415-0","author":"I Vercellino","year":"2022","unstructured":"Vercellino I, Sazanov LA (2022) The assembly, regulation and function of the mitochondrial respiratory chain. Nat Rev Mol Cell Biol. https:\/\/doi.org\/10.1038\/s41580-021-00415-0","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6062_CR65","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"SC Cunnane","year":"2020","unstructured":"Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, Beal MF et al (2020) Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov 19:609\u2013633. https:\/\/doi.org\/10.1038\/s41573-020-0072-x","journal-title":"Nat Rev Drug Discov"},{"key":"6062_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/biology8020038","author":"C Chen","year":"2019","unstructured":"Chen C, Turnbull DM, Reeve AK (2019) Mitochondrial dysfunction in Parkinson\u2019s disease\u2014cause or consequence? Biology (Basel). https:\/\/doi.org\/10.3390\/biology8020038","journal-title":"Biology (Basel)"},{"key":"6062_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.03.010","author":"N Maio","year":"2017","unstructured":"Maio N, Kim KS, Singh A, Rouault TA (2017) A Single Adaptable Cochaperone-Scaffold Complex Delivers Nascent Iron-Sulfur Clusters to Mammalian Respiratory Chain Complexes I-III. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2017.03.010","journal-title":"Cell Metab"},{"key":"6062_CR68","doi-asserted-by":"publisher","DOI":"10.1080\/10715762.2017.1315114","author":"A Umeno","year":"2017","unstructured":"Umeno A, Biju V, Yoshida Y (2017) In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer\u2019s disease, Parkinson\u2019s disease, and diabetes. Free Radic Res. https:\/\/doi.org\/10.1080\/10715762.2017.1315114","journal-title":"Free Radic Res"},{"key":"6062_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.114639","author":"R Zeng","year":"2019","unstructured":"Zeng R, Wang X, Zhou Q, Fu X, Wu Q, Lu Y, Shi J et al (2019) Icariin protects rotenone-induced neurotoxicity through induction of SIRT3. Toxicol Appl Pharmacol. https:\/\/doi.org\/10.1016\/j.taap.2019.114639","journal-title":"Toxicol Appl Pharmacol"},{"key":"6062_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2014.12.035","author":"L Liu","year":"2015","unstructured":"Liu L, Peritore C, Ginsberg J, Shih J, Arun S, Donmez G (2015) Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson\u2019s disease. Behav Brain Res. https:\/\/doi.org\/10.1016\/j.bbr.2014.12.035","journal-title":"Behav Brain Res"},{"key":"6062_CR71","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.355206","author":"W Yu","year":"2012","unstructured":"Yu W, Dittenhafer-Reed KE, Denu JM (2012) SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M112.355206","journal-title":"J Biol Chem"},{"key":"6062_CR72","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-19-0103","author":"X Tang","year":"2020","unstructured":"Tang X, Fu X, Liu Y, Yu D, Cai SJ, Yang C (2020) Blockade of glutathione metabolism in IDH1-mutated glioma. Mol Cancer Ther. https:\/\/doi.org\/10.1158\/1535-7163.MCT-19-0103","journal-title":"Mol Cancer Ther"},{"key":"6062_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101107","author":"ZD Zhou","year":"2020","unstructured":"Zhou ZD, Tan EK (2020) Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson\u2019s disease. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2020.101107","journal-title":"Ageing Res Rev"},{"key":"6062_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.04.002","author":"M Uldry","year":"2006","unstructured":"Uldry M, Yang W, St-Pierre J, Lin J, Seale P, Spiegelman BM (2006) Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2006.04.002","journal-title":"Cell Metab"},{"key":"6062_CR75","doi-asserted-by":"publisher","unstructured":"Lerin C, Rodgers JT, Kalume DE, Kim Sh, Pandey A, Puigserver P (2006) GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1\u03b1. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2006.04.013","DOI":"10.1016\/j.cmet.2006.04.013"},{"key":"6062_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601633","author":"Z Gerhart-Hines","year":"2007","unstructured":"Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW et al (2007) Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1\/PGC-1\u03b1. EMBO J. https:\/\/doi.org\/10.1038\/sj.emboj.7601633","journal-title":"EMBO J"},{"key":"6062_CR77","doi-asserted-by":"publisher","DOI":"10.5851\/kosfa.2019.e93","author":"ES Kang","year":"2020","unstructured":"Kang ES, Kim HJ, Han SG, Seo HG (2020) Duck oil-loaded nanoemulsion inhibits senescence of angiotensin II-treated vascular smooth muscle cells by upregulating SIRT1. Food Sci Anim Resour. https:\/\/doi.org\/10.5851\/kosfa.2019.e93","journal-title":"Food Sci Anim Resour"},{"key":"6062_CR78","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.8396","author":"W Tong","year":"2019","unstructured":"Tong W, Chen X, Song X, Chen Y, Jia R, Zou Y, Li L et al (2019) Resveratrol inhibits LPS-induced inflammation through suppressing the signaling cascades of TLR4-NF-\u03baB\/MAPKs\/IRF3. Exp Ther Med. https:\/\/doi.org\/10.3892\/etm.2019.8396","journal-title":"Exp Ther Med"},{"key":"6062_CR79","doi-asserted-by":"publisher","unstructured":"Salvatori I, Valle C, Ferri A, Carr\u00ec MT (2017) SIRT3 and mitochondrial metabolism in neurodegenerative diseases. Neurochem Int 109. https:\/\/doi.org\/10.1016\/j.neuint.2017.04.012","DOI":"10.1016\/j.neuint.2017.04.012"},{"key":"6062_CR80","doi-asserted-by":"publisher","unstructured":"Iuzzolino A, Pellegrini FR, Rotili D, Degrassi F, Trisciuoglio D (2024) The \u03b1-tubulin acetyltransferase ATAT1: structure, cellular functions, and its emerging role in human diseases. Cell Mol Life Sci 81:. https:\/\/doi.org\/10.1007\/s00018-024-05227-x","DOI":"10.1007\/s00018-024-05227-x"},{"key":"6062_CR81","doi-asserted-by":"publisher","unstructured":"Patel VP, Chu CT (2014) Decreased SIRT2 activity leads to altered microtubule dynamics in oxidatively-stressed neuronal cells: implications for Parkinson\u2019s disease. Exp Neurol 257. https:\/\/doi.org\/10.1016\/j.expneurol.2014.04.024","DOI":"10.1016\/j.expneurol.2014.04.024"},{"key":"6062_CR82","doi-asserted-by":"publisher","unstructured":"Zhu C, Herbst S, Lewis PA (2023) Leucine-rich repeat kinase 2 at a glance. J Cell Sci 136. https:\/\/doi.org\/10.1242\/jcs.259724","DOI":"10.1242\/jcs.259724"},{"key":"6062_CR83","doi-asserted-by":"publisher","unstructured":"Leal MC, Casabona JC, Puntel M, Pitossi FJ (2013) Interleukin-1\u03b2 and tumor necrosis factor-\u03b1: reliable targets forprotective therapies in Parkinson\u2019s disease? Front Cell Neurosci 7:53. https:\/\/doi.org\/10.3389\/fncel.2013.00053","DOI":"10.3389\/fncel.2013.00053"},{"key":"6062_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046364","author":"H Yang","year":"2012","unstructured":"Yang H, Zhang W, Pan H, Feldser HG, Lainez E, Miller C, Leung S et al (2012) SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-\u03baB activity. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0046364","journal-title":"PLoS ONE"},{"key":"6062_CR85","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2023.0203","author":"H Xiao","year":"2023","unstructured":"Xiao H, Xie Y, Xi K, Xie J, Liu M, Zhang Y, Cheng Z et al (2023) Targeting mitochondrial sirtuins in age-related neurodegenerative diseases and fibrosis. Aging Dis. https:\/\/doi.org\/10.14336\/AD.2023.0203","journal-title":"Aging Dis"},{"key":"6062_CR86","doi-asserted-by":"publisher","unstructured":"Sun X, Pang H, Li J, Luo S, Huang G, Li X, Xie Z et al (2020) The NLRP3 inflammasome and its role in T1DM. Front Immunol 11:1595. https:\/\/doi.org\/10.3389\/fimmu.2020.01595","DOI":"10.3389\/fimmu.2020.01595"},{"key":"6062_CR87","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/9335166","author":"L Mao","year":"2023","unstructured":"Mao L, Wu DH, Hu GH, Fan JH (2023) TLR4 enhances cerebral ischemia\/reperfusion injury via regulating NLRP3 inflammasome and autophagy. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2023\/9335166","journal-title":"Mediators Inflamm"},{"key":"6062_CR88","doi-asserted-by":"publisher","unstructured":"Klemmensen MM, Borrowman SH, Pearce C, Pyles B, Chandra B (2024) Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics 21. https:\/\/doi.org\/10.1016\/j.neurot.2023.10.002","DOI":"10.1016\/j.neurot.2023.10.002"},{"key":"6062_CR89","doi-asserted-by":"publisher","unstructured":"Chandra SR (2017) Alzheimer\u2019s disease: An alternative approach. Indian J Med Res 145:.https:\/\/doi.org\/10.4103\/ijmr.IJMR_74_17","DOI":"10.4103\/ijmr.IJMR_74_17"},{"key":"6062_CR90","doi-asserted-by":"publisher","unstructured":"Raskin J, Cummings J, Hardy J, Schuh K, Dean R (2015) Neurobiology of Alzheimer\u2019s Disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions. Curr Alzheimer Res 12:. https:\/\/doi.org\/10.2174\/1567205012666150701103107","DOI":"10.2174\/1567205012666150701103107"},{"key":"6062_CR91","doi-asserted-by":"crossref","unstructured":"Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S, Mucke L et al. SIRT1 protects against microglia-dependent amyloid-\u03b2 toxicity through inhibiting NF-\u03baB signaling. J Biol Chem 280(48):40364-40374","DOI":"10.1074\/jbc.M509329200"},{"key":"6062_CR92","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2369-17.2018","author":"SW Min","year":"2018","unstructured":"Min SW, Sohn PD, Li Y, Devidze N, Johnson JR, Krogan NJ, Masliah E et al (2018) SIRT1 deacetylates tau and reduces pathogenic tau spread in a mouse model of tauopathy. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.2369-17.2018","journal-title":"J Neurosci"},{"key":"6062_CR93","doi-asserted-by":"publisher","unstructured":"Gatto EM, Rojas NG, Persi G, Etcheverry JL, Cesarini ME, Perandones C (2020) Huntington disease: advances in the understanding of its mechanisms. Clin Park Relat Disord 3.https:\/\/doi.org\/10.1016\/j.prdoa.2020.100056.","DOI":"10.1016\/j.prdoa.2020.100056"},{"key":"6062_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073845","author":"H Tong","year":"2024","unstructured":"Tong H, Yang T, Xu S, Li X, Liu L, Zhou G, Yang S et al (2024) Huntington\u2019s disease: complex pathogenesis and therapeutic strategies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25073845","journal-title":"Int J Mol Sci"},{"key":"6062_CR95","doi-asserted-by":"publisher","unstructured":"He H, Yu FX, Sun C, Luo Y (2011) CBP\/p300 and SIRT1 are involved in transcriptional regulation of S-Phase specific histone genes. PLoS One 6. https:\/\/doi.org\/10.1371\/journal.pone.0022088","DOI":"10.1371\/journal.pone.0022088"},{"key":"6062_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2559","author":"H Jeong","year":"2012","unstructured":"Jeong H, Cohen DE, Cui L, Supinski A, Savas JN, Mazzulli JR, Yates JR et al (2012) Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat Med. https:\/\/doi.org\/10.1038\/nm.2559","journal-title":"Nat Med"},{"key":"6062_CR97","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-060909-153248","author":"MP Coleman","year":"2010","unstructured":"Coleman MP, Freeman MR (2010) Wallerian degeneration, WldS, and Nmnat. Annu Rev Neurosci. https:\/\/doi.org\/10.1146\/annurev-neuro-060909-153248","journal-title":"Annu Rev Neurosci"},{"key":"6062_CR98","doi-asserted-by":"publisher","unstructured":"Walker LJ, Summers DW, Sasaki Y, Brace EJ, Milbrandt J, DiAntonio A (2017) MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2. Elife 6. https:\/\/doi.org\/10.7554\/eLife.22540","DOI":"10.7554\/eLife.22540"},{"key":"6062_CR99","doi-asserted-by":"publisher","unstructured":"Peggion C, Scalcon V, Massimino ML, Nies K, Lopreiato R, Rigobello MP, Bertoli A (2022) SOD1 in ALS: Taking stock in pathogenic mechanisms and the role of glial and muscle cells. Antioxidants 11. https:\/\/doi.org\/10.3390\/antiox11040614","DOI":"10.3390\/antiox11040614"},{"key":"6062_CR100","doi-asserted-by":"publisher","unstructured":"Villapol S (2018) Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation. Cell Mol Neurobiol 38. https:\/\/doi.org\/10.1007\/s10571-017-0554-5","DOI":"10.1007\/s10571-017-0554-5"},{"key":"6062_CR101","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.5034","author":"XD Zou","year":"2016","unstructured":"Zou XD, Guo SQ, Hu ZW, Li WL (2016) NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2016.5034","journal-title":"Mol Med Rep"},{"key":"6062_CR102","doi-asserted-by":"publisher","unstructured":"Liu J, Jiang J, Qiu J, Wang L, Zhuo J, Wang B, Sun D et al (2022) Urolithin A protects dopaminergic neurons in experimental models of Parkinson\u2019s disease by promoting mitochondrial biogenesis through the SIRT1\/PGC-1\u03b1 signaling pathway. Food Funct 13. https:\/\/doi.org\/10.1039\/d1fo02534a","DOI":"10.1039\/d1fo02534a"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06062-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06062-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06062-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:06:51Z","timestamp":1784268411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06062-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6062"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06062-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"775"}}